As posted in the ASCO Daily News, Dr. George Demetri, has received recognition for his work in developing targeted TKIs for GIST.
Whisky aficionados gathered for the 3rd Annual Water of Life Fall event (WOLF) to enjoy whisky and raise funds for #GISTresearch.
GIST Research Updates and Future Direction of Research presented by Dr. Ping Chi at New Horizons 2019 in Wayne, NJ.
Deciphera Pharmaceuticals has released positive results from their INVICTUS Phase 3 Clinical Study of Ripretinib in patients with GIST. They have also updated results from the Phase 1 Study. Deciphera shared that "patients treated [...]
Click on image to see Patient Registry in Review 2018 The Life Raft Group has played an instrumental role in bridging the gap between patients with valuable clinical Gastrointestinal Stromal Tumor (GIST) [...]
PDF is available of LRG Science to print here. Real World Evidence in Action Although targeted medicine has brought about immense progress in cancer treatment, there are still enormous challenges [...]
Senior Director of Program Operations, Sara Rothschild, recently represented the Life Raft Group at the SPAEN (Sarcoma Patients EuroNet) meeting. Subsequent to the meeting, over 300 medical professionals gathered for the 7th annual ESMO [...]
Columbia University Medical Center, New York-Presbyterian and the Life Raft Group have entered into a collaborative effort to advance research to find a cure for GIST using a novel therapeutic approach and patient-driven data. [...]
The Life Raft Group became a formal non-profit on June 10, 2002. Begun as a grass roots effort by a group of men and women with a deadly cancer in 2000, by the year [...]
The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals [...]